353 results on '"Ruhé, Henricus G."'
Search Results
2. From smartphone data to clinically relevant predictions: A systematic review of digital phenotyping methods in depression
3. Uncovering social states in healthy and clinical populations using digital phenotyping and Hidden Markov Models
4. Efficacy and safety of selegiline across different psychiatric disorders: A systematic review and meta-analysis of oral and transdermal formulations
5. Functional MRI correlates of emotion regulation in major depressive disorder related to depressive disease load measured over nine years
6. Neurometabolite changes in response to antidepressant medication: A systematic review of 1H-MRS findings
7. Discontinuation of psychotropic medication: a synthesis of evidence across medication classes
8. The association between sample and treatment characteristics and the efficacy of repetitive transcranial magnetic stimulation in depression: A meta-analysis and meta-regression of sham-controlled trials
9. Suicidal ideation in remitted major depressive disorder predicts recurrence
10. The relationship between dose and serotonin transporter occupancy of antidepressants—a systematic review
11. Molecular Imaging of Depressive Disorders
12. Decreased reward circuit connectivity during reward anticipation in major depression
13. Increasing the bioavailability of oral esketamine by a single dose of cobicistat: A case study.
14. Depression recurrence is accompanied by longer periods in default mode and more frequent attentional and reward processing dynamic brain‐states during resting‐state activity
15. Attentional control, rumination and recurrence of depression
16. Bipolar Disorders
17. Molecular Imaging of Depressive Disorders
18. Correction to: Metabolic features of recurrent major depressive disorder in remission, and the risk of future recurrence
19. Metabolic features of recurrent major depressive disorder in remission, and the risk of future recurrence
20. Longitudinal evidence for a relation between depressive symptoms and quality of life in schizophrenia using structural equation modeling
21. Differential relations of suicidality in depression to brain activation during emotional and executive processing
22. Neurometabolite changes in response to antidepressant medication: a systematic review of1H-MRS findings
23. A state-independent network of depressive, negative and positive symptoms in male patients with schizophrenia spectrum disorders
24. A symptom network structure of the psychosis spectrum
25. Altered functional connectivity during self- and close other-reflection in patients with bipolar disorder with past psychosis and patients with schizophrenia
26. The Dutch Measure for quantification of Treatment Resistance in Depression (DM-TRD): an extension of the Maudsley Staging Method
27. Functional MRI Correlates of Emotion Regulation in Major Depressive Disorder Related to Depressive Disease Load Measured Over Nine Years
28. Bipolar Disorders
29. Molecular Imaging of Depressive Disorders
30. Adding mindfulness-based cognitive therapy to maintenance antidepressant medication for prevention of relapse/recurrence in major depressive disorder: Randomised controlled trial
31. Erythrocyte fatty acid profiles and plasma homocysteine, folate and vitamin B6 and B12 in recurrent depression: Implications for co-morbidity with cardiovascular disease
32. Fatty acid metabolism and its longitudinal relationship with the hypothalamic–pituitary–adrenal axis in major depression: Associations with prospective antidepressant response
33. The prescriber’s guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression
34. The decision tool unipolar depression (DTUD): a new measure to facilitate the early identification of patients with major depressive disorder in need of highly specialized care
35. On the Origins of MAOI Misconceptions: Reaffirming their Role in Melancholic Depression.
36. Longitudinal effects of the SSRI paroxetine on salivary cortisol in Major Depressive Disorder
37. Segregation of dynamic resting-state reward, default mode and attentional networks after remitted patients transition into a recurrent depressive episode
38. Negative cognitive schema modification as mediator of symptom improvement after electroconvulsive therapy in major depressive disorder
39. Neuroinflammation in bipolar disorder – A [11C]-(R)-PK11195 positron emission tomography study
40. The prescriber’s guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression
41. Occupancy of serotonin transporters in the amygdala by paroxetine in association with attenuation of left amygdala activation by negative faces in major depressive disorder
42. Seeing the signs: Using the course of residual depressive symptomatology to predict patterns of relapse and recurrence of major depressive disorder
43. Neural response to alcohol taste cues in youth: effects of the OPRM1 gene
44. Aberrant default-mode network-hippocampus connectivity after sad memory-recall in remitted-depression
45. Neural correlates of dysfunctional emotion regulation in major depressive disorder. A systematic review of neuroimaging studies
46. Relationship between the hypothalamic–pituitary–adrenal-axis and fatty acid metabolism in recurrent depression
47. Longitudinal hypothalamic–pituitary–adrenal axis trait and state effects in recurrent depression
48. Staging methods for treatment resistant depression. A systematic review
49. Repeated, low-dose oral esketamine in patients with treatment-resistant depression: pilot study
50. Impact of Comorbid Personality Disorders on Depression Treatment in Routine Outpatient Care
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.